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Abstract
Background: Several authors advocate spleen preserving distal pancreatectomy, because of the
increased complication rate after splenectomy.
Methods: Postoperative complications and survival after distal and total pancreatectomy, were
recorded and retrospectively analyzed according to spleen preservation. Patients, who underwent
distal and total pancreatectomy without histologically proven adenocarcinoma, or extrapancreatic
disease, were included in the cohort which was divided into splenectomy and no splenectomy
groups. Statistical analysis was performed using Fisher's test.
Results: The study group consisted of 62 patients who underwent distal and total pancreatectomy
between 26/11/1987 to 6/1/2006. Splenectomy was performed in 35 out of 62 patients (56.5%),
distal pancreatectomy was performed in 49 out of 62 patients (79%). Morbidity rate was 28.6% in
splenectomy group and 14.8% in the no splenectomy group (p = 0.235), while 30 days mortality
rate was 2.9%; one patient died in the splenectomy group (p = 1).
Conclusion:  Spleen-preservation did not influence the outcomes after distal and total
pancreatectomy in our series.
Background
Pancreatectomy may be accompanied with splenectomy
in distal and total pancreatic resections. Elective periph-
eral pancreatectomy is safer than pancreaticoduodenec-
tomy, but carries a high morbidity rate [1-4];
intraabdominal abscess, intraabdominal hemorrhage and
pancreatic fistula are the main causes [5-9]. In the past
decade splenectomy was associated with increased septic
complications rate [10,11]. Furthermore, several authors
[12-15], suggested spleen preserving distal pancreatec-
tomy in order to reduce postoperative septic complica-
tions[16]. The technique of spleen preserving distal
pancreatectomy and its absolute and relative contraindi-
cations have been described elsewhere [3,13,17,18]. Few
retrospective studies have analyzed the influence of
splenectomy in the postoperative course after distal pan-
createctomy, while one study has analyzed this relation-
ship after total pancreatectomy [3,19,20]. These studies
included patients with benign diseases [21]; mainly with
chronic pancreatitis [3]; only with chronic pancreatitis
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[22]; with malignant and benign diseases [9,23] ; mainly
with pancreatic trauma [19] and only with adenocarci-
noma [20].
In our study, postoperative complications after distal and
total pancreatectomy, were recorded and analyzed accord-
ing to spleen preservation, in patients with pancreatitis
(chronic and acute), benign neoplasms and other benign
diseases.
Patients and methods
Prospective collected data were retrospectively analyzed
for patients who underwent distal or total pancreatectomy
with or without splenectomy between 28th of November
1987 and 6th of January 2006. Patients with histologically
proven adenocarcinoma, patients with cystadenocarci-
noma, patients who underwent completion pancreatec-
tomy after postoperative complication of
pancreaticoduodenectomy, patients who underwent pan-
createctomy because of abdominal trauma, patients who
had hepatic metastases in laparotomy, patients who had
cancer in the pancreatic head or lower common bile duct
and patients who had additional procedures such as gast-
rectomy and colectomy were excluded from the study. The
patients were divided into splenectomy and no splenec-
tomy group. The following parameters were recorded and
analyzed for each of the above mentioned groups: sepsis
(SIRS and MODS), acute renal failure, pulmonary compli-
cations (atelectasia, pneumonia, pleural effusion), ARDS
(acute onset, bilateral infiltrates on chest radiography,
pulmonary-artery wedge pressure ≤ 1 8  m m  H g  o r  t h e
absence of clinical evidence of left atrial hypertension,
acute lung injury considered to be present if PaO2 :FiO2 is
≤ 300 Acute respiratory distress syndrome considered to
be present if PaO2 :FiO2 is ≤ 200), cardiac complications
(atrial fibrillation, dysarrythmia), central nervous system
complications (confusion, stroke), intra abdominal
abscess (defined as an infected fluid collection identified
by CT or ultrasound scan-guided needle aspiration and
microbiologic culture), postoperative primary intra
abdominal hemorrhage (1ry IA, diagnosed by the pres-
ence of fresh blood through the drains or by hypovolemic
shock and abdominal distension in patients without
drains), postoperative primary gastrointestinal hemor-
rhage (1ry GI), delayed gastric emptying, wound infec-
tion, wound dehiscence, first 30 postoperative days
mortality.
Statistical analysis was performed using Fisher's two-
tailed test, in the "Statistical Package for the Social Sci-
ences" version 12 for Windows (SPSS®, Chicago, IL, USA).
A p value less than 0.05 was considered significant.
Results
Hospital data included 160 patients who underwent distal
and total pancreatectomy between 28th  of November
1987 and 6th of January 2006. Histologically proven ade-
nocarcinoma had 31 patients, 20 patients had additional
procedures, 13 patients had liver or peritoneal metastases
at laparotomy, 11 patients had cystadenocarcinoma, 5
patients underwent laparotomy for abdominal trauma
and 17 underwent surgery for other non benign diseases
(data available but not shown). After fulfilling the exclu-
sion criteria, our study group consisted of the rest 62
patients who underwent total and distal pancreatectomy
with or without splenectomy. The demography, types of
operations and final diagnoses are shown in Tables 1 and
2. Splenectomy was performed in 35 out of 62 patients
(56.5%), distal pancreatectomy was performed in 49 out
of 62 patients (79%). Morbidity rate was 28.6% (10
patients) in splenectomy group and 14.8% (4 patients) in
the no splenectomy group (p = 0.235). According the type
of surgery, the morbidity rate was 24.1% in distal pancre-
atectomy with splenectomy and 15% in distal pancreatec-
tomy without splenectomy (p = 0.496), while in total
pancreatectomy with or without splenectomy was 50%
and 14.3% respectively (p = 0.266).
Table 1: Study group characteristics and types of operations.
N (%)
Sex
Male 30 (48,4%)
Female 32 (51,6%)
Age (years)
Median 52
Range 22–87
Type of pancreatectomies
Distal+splenectomy 29
Total+splenectomy 6
Distal (spleen preservation) 20
Total (spleen preservation) 7World Journal of Surgical Oncology 2007, 5:61 http://www.wjso.com/content/5/1/61
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Splenectomy vs no splenectomy group
Using the Fisher's test no studied factor was correlated
with splenectomy vs no splenectomy groups (Table 3).
Interestingly all the patients with postoperative sepsis
were in the splenectomy group, but the difference was not
statistically significant (p = 0.250).
The two cases of intra abdominal access were treated by
the radiologist with a CT guided drainage. The only case
of primary postoperative hemorrhage needed a reinter-
vention after a failed embolization.
30 days mortality analysis
The 30 days mortality rate in the study group of patients
was 2.9%. One patient died (stroke) in the splenectomy
group (p = 1). There was not recorded any postoperative
death due to postsplenectomy sepsis.
Discussion
Spleen preserving distal pancreatectomy has been advo-
cated by many authors, because of splenectomy associ-
ated immunologic alterations and septic postoperative
complications [13,16,24,25]. Holdsworth et al., [15] and
Benoist et al., [21] studied patients with benign diseases
and Sledzianowski et al., [26] studied patients with malig-
nant and benign diseases, failed to prove the importance
of spleen preservation in distal pancreatectomy, support-
ing the fact that the risk of overwhelming postsplenec-
tomy sepsis in adult population with benign disease is
very low (0.28%–1.9% with a 2.2% mortality rate)
[15,27]. Aldridge et al., [3] in a group of patients with
chronic pancreatitis concluded that postoperative course
was similar after distal pancreatectomy regardless of
splenectomy. Richardson and Scott- Conner [19] demon-
strated that spleen preservation did not increase the com-
plications rate after distal pancreatectomy. However, the
study group was small (21 patients), and mainly consisted
of trauma patients who underwent major additional pro-
cedures in most of the cases. Schwarz et al., [20] studied
the outcomes in a group of patients (326 patients, 37
underwent splenectomy) with adenocarcinoma after dis-
tal and total pancreatectomy with or without splenec-
tomy, concluded that splenectomy was a statistically
significant unfavorable prognostic factor in survival, but
not in postoperative morbidity. Shoup et al., [23], in a
cohort with benign and low-grade malignant diseases
(125 patients), reported that spleen preserving distal pan-
createctomy is associated with lower infectious complica-
tions rate and reduced hospital stay, than the distal
pancreatectomy with splenectomy (p = 0.01 and p < 0.01
respectively). To our knowledge, there is no other series,
studying the relation of spleen preservation with all the
Table 3: Analysis of complications in splenectomy and no splenectomy groups.
Complications Splenectomy 
group (n)
No splenectomy 
group (n)
p Complications Splenectomy 
group (n)
No splenectomy 
group (n)
p
Sepsis 30 0.250 Renal failure 10 1
Pulmonary 10 1D G E * 20 0.5
Intrabdominal abscess 11 11 r y  I A  * 10 1
Wound infection 12 0.575 Cardiac 00 -
Wound dehiscense 11 1C N S * 10 1
ARDS 10 11 r y  G I * 01 0.435
*(1ry IA = primary intra abdominal haemhorrage, 1ry GI = primary gatrointestinal haemhorrage, CNS = Central Nervous System, DGE = Delayed 
gastric emptying).
Table 2: Final diagnoses after pancreatic resection in the total of 62 patients.
Final diagnoses Frequency
Pancreatitis
Chronic 19
Acute 6
Benign Neoplasms
Adenoma 1
Papilloma 1
Insulinoma 5
Gastrinoma 1
Pseudopapillary tumor 4
Other benign diseases
Benign neuroendocrine tumor 4
Cystadenoma 14
Pseudocyst 7World Journal of Surgical Oncology 2007, 5:61 http://www.wjso.com/content/5/1/61
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postoperative parameters we recorded together, after dis-
tal and total pancreatectomy. Infectious complications
including wound and pulmonary complications, intra
abdominal abscess formation and sepsis were not statisti-
cally significant associated with splenectomy. There was
no significant obvious predilection in the selection of dis-
tal or total pancreatectomy and splenectomy or spleen
preservation. The mortality rate recorded in our cohort is
similar to the reported in some studies [1,2] and lower
than the published in other articles [3,4,28] after distal
pancreatectomy. In our series there was not statistically
significant difference recorded in morbidity, in the first 30
postoperative days mortality (p = 0.592 respectively). In
order to fully assess the influence of splenectomy on sur-
vival after distal and total pancreatectomy, future studies
including larger series of patients are required.
Conclusion
The authors conclude that spleen preservation does not
influence the outcome after distal or total pancreatec-
tomy, in benign diseases and selected benign neoplasms.
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